Multiple Sclerosis Center- Site Number : 8400143

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Multiple sclerosis2 trials

Phase

• Phase 32 trials

Status

• Completed2 trials

Lead sponsor

• Sanofi2 trials

Closed trials

• Completed

  Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (HERCULES)

  NCT04411641· Phase 3· Sanofi· Source

• Completed

  Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (PERSEUS)

  NCT04458051· Phase 3· Sanofi· Source